Results

Tina Smith

09/30/2026 | Press release | Distributed by Public on 09/30/2026 18:25

U.S. Senator Tina Smith’s Legislation to Combat Lyme Disease & Other Tick-Borne Diseases Becomes Law

Most recent data shows Minnesota recorded 3,551 cases in 2024 alone, a rate that has likely increased in recent years

WASHINGTON, D.C. - U.S. Senator Tina Smith's (D-MN) bipartisan bill to expand research, testing and treatment for Lyme and other tick-borne diseases has been signed into law by the President. The Kay Hagan Tick Reauthorization Act passed the U.S. Senate in August, passed the U.S. House of Representatives in mid-September.

"The number of Lyme disease and other tick-borne illnesses has been rising at an alarming rate. This law will step up regional efforts at researching, testing and treating Lyme and other tick-borne diseases. We must cut down on tick-borne illnesses for the sake of Americans' health and well-being," said Sen. Smith. "This law will save lives, especially in states like Minnesota, where tick populations have been rising."

Over the past two decades, Minnesota has experienced a significant rise in tick-borne diseases. According to the Minnesota Department of Health, Lyme disease remains the state's most reported tick-borne illness, with 3,551 probable cases reported in 2024. In the same year, Minnesota also reported hundreds of cases of other tickborne diseases: 627 cases of anaplasmosis, 89 cases of babesiosis and 14 cases of Powassan virus disease.

The bill, co-led by Sen. Susan Collins (R-ME), was named in honor of former Sen. Kay Hagan (D-NC), who passed away on October 28, 2019, due to complications from the tick-borne Powassan virus.

Using a three-pronged approach, The Kay Hagan Tick Reauthorization Act will:

  1. Continue implementation and updates of the Department of Health and Human Services' National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People.

This will support ongoing federal efforts to advance research, improve diagnostics and strengthen coordination on vector-borne diseases.

  1. Reauthorize the Regional Centers of Excellence in Vector-Borne Disease for five years.

These centers support critical research, surveillance and public health efforts to address tick-borne diseases and other vector-borne threats.

  1. Reauthorize CDC grants to state health departments to strengthen vector-borne disease prevention and response efforts.

These grants will support surveillance, early detection and diagnosis, treatment efforts, public education, and partnerships to address Lyme disease and other vector-borne diseases.

###

Tina Smith published this content on September 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2026 at 00:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]